IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PAGNESI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.957
NA - Nord America 2.389
EU - Europa 1.235
SA - Sud America 754
AF - Africa 79
OC - Oceania 5
Totale 7.419
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.276
SG - Singapore 1.054
CN - Cina 693
BR - Brasile 623
IT - Italia 414
HK - Hong Kong 404
VN - Vietnam 240
BD - Bangladesh 223
DE - Germania 172
FR - Francia 140
GB - Regno Unito 112
RU - Federazione Russa 101
TR - Turchia 98
FI - Finlandia 69
IN - India 61
CA - Canada 56
AR - Argentina 45
PL - Polonia 38
JP - Giappone 36
ZA - Sudafrica 33
MX - Messico 32
NL - Olanda 29
IE - Irlanda 26
SA - Arabia Saudita 25
UA - Ucraina 24
AT - Austria 22
IQ - Iraq 22
ES - Italia 21
ID - Indonesia 21
CO - Colombia 18
EC - Ecuador 18
SE - Svezia 14
PY - Paraguay 13
PK - Pakistan 12
CL - Cile 11
EG - Egitto 11
VE - Venezuela 11
CZ - Repubblica Ceca 10
MA - Marocco 10
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
TN - Tunisia 8
PE - Perù 7
AZ - Azerbaigian 6
JM - Giamaica 6
KE - Kenya 6
LT - Lituania 6
BO - Bolivia 5
LV - Lettonia 5
MD - Moldavia 5
IR - Iran 4
JO - Giordania 4
NP - Nepal 4
OM - Oman 4
PA - Panama 4
PH - Filippine 4
PS - Palestinian Territory 4
SC - Seychelles 4
BA - Bosnia-Erzegovina 3
HN - Honduras 3
HU - Ungheria 3
IL - Israele 3
KZ - Kazakistan 3
NO - Norvegia 3
RS - Serbia 3
SN - Senegal 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AU - Australia 2
CH - Svizzera 2
CR - Costa Rica 2
GE - Georgia 2
KG - Kirghizistan 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BW - Botswana 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
FJ - Figi 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
PR - Porto Rico 1
Totale 7.411
Salva come PNG Salva come JPEG
Città #
Singapore 517
Hong Kong 401
Ashburn 274
San Jose 259
Beijing 193
The Dalles 170
New York 139
Los Angeles 127
Lauterbourg 98
Ho Chi Minh City 96
Dallas 85
Istanbul 75
Chandler 67
Milan 65
Munich 56
Redondo Beach 54
São Paulo 54
Moscow 48
Chicago 47
Hanoi 46
Romola 44
Boardman 43
Buffalo 39
San Francisco 37
Council Bluffs 36
Helsinki 36
Tokyo 34
Frankfurt am Main 32
London 31
Orem 29
Santa Clara 29
Shanghai 27
Dublin 26
Montreal 25
Rome 25
Brooklyn 24
Princeton 24
Warsaw 23
Brescia 22
Denver 19
Poplar 19
Boston 17
Guangzhou 16
Johannesburg 16
Lappeenranta 16
Nuremberg 16
Phoenix 16
Atlanta 15
Chennai 15
Haiphong 15
Amsterdam 14
Mexico City 14
Stockholm 14
Düsseldorf 13
Toronto 13
Turku 13
Riyadh 12
Brasília 11
Rio de Janeiro 11
Ankara 10
Changsha 10
Charlotte 10
Curitiba 10
Quito 10
Tianjin 10
Vienna 10
Houston 9
Manaus 9
Ribeirão Preto 9
Washington 9
Biên Hòa 8
City of London 8
Salt Lake City 8
Belo Horizonte 7
Da Nang 7
Hangzhou 7
Manchester 7
Medellín 7
Naples 7
New Delhi 7
Querétaro 7
Strasbourg 7
Tashkent 7
Thái Bình 7
Asunción 6
Baku 6
Brno 6
Campina Grande 6
Campinas 6
Chengdu 6
Des Moines 6
Florence 6
Itajaí 6
Lima 6
Mumbai 6
Porto Alegre 6
Ribeirão das Neves 6
Salvador 6
Turin 6
West Jordan 6
Totale 4.055
Salva come PNG Salva come JPEG
Nome #
2024 update in heart failure 164
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 113
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 111
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 106
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF 101
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 101
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 95
Ventilation strategies in cardiogenic shock: Insights from the AltShock-2 registry 93
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors 92
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 90
Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions 90
Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry 88
Prognostic significance of serum potassium in patients hospitalized for acute heart failure 87
Organ perfusion pressure predicts outcomes in cardiogenic shock patients 87
Vericiguat for Heart Failure with Reduced Ejection Fraction 87
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 86
Telemedicine for the treatment of heart failure: new opportunities after COVID-19 86
Frailty according to the 2019 HFA-ESC definition in patients at risk for advanced heart failure: Insights from the HELP-HF registry 85
Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure: Insights From the RELAX-AHF-2 Trial 85
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 85
April 2021 at a glance: focus on systolic function, quality of life and treatment in heart failure 85
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 84
Prognostic value of right ventricular longitudinal strain in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair 83
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 83
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure 83
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF 83
Predicting survival in patients with severe heart failure: Risk score validation in the HELP-HF cohort 83
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk 82
Impact of malnutrition in patients with severe heart failure 81
Towards a phenotype profiling of the patients with heart failure and preserved ejection fraction 80
Heart failure: an update from the last years and a look at the near future 80
High troponin levels in patients hospitalized for coronavirus disease 2019: a maker or a marker of prognosis? 80
Combined pre- and post-capillary pulmonary hypertension in left heart disease 78
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 77
Malnutrition and outcomes in patients with tricuspid regurgitation undergoing transcatheter tricuspid valve repair 76
Characteristics, Prognosis and ESC/ERS Risk Stratification in Obese Patients with Pulmonary Arterial Hypertension (PAH) 75
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 75
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials 73
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 73
Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysis 73
Right ventricular thrombosis: from a case report to pathophysiology mechanisms and current treatment options 72
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 71
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial 71
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli 71
Clinical Impact of Renal Dysfunction in Patients with Severe Tricuspid Regurgitation and Chronic Heart Failure 70
Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure 70
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial 69
Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment 69
Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists 68
Acute Heart Failure: Transitioning From Symptom-Based Care to Remission 68
Prognostic role of tricuspid annular plane systolic excursion/pulmonary artery systolic pressure ratio in patients hospitalized for acute heart failure 67
Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation 67
Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis 67
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 66
Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial 66
Transcatheter edge-to-edge mitral valve repair for post-myocardial infarction papillary muscle rupture and acute heart failure: A systematic review 65
Medical therapy for heart failure with preserved ejection fraction: Still a minefield, but with new hope 65
Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients with Pre Cardiogenic Shock 64
Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE 63
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 63
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial 62
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 62
Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction 61
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 60
March 2021 at a glance: focus on epidemiology, prevention and COVID-19 60
Incidence, Predictors, and Prognostic Impact of New Permanent Pacemaker Implantation After TAVR With Self-Expanding Valves 60
Deep phenotype characterization of hypertensive response to exercise: implications on functional capacity and prognosis across the heart failure spectrum 60
Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF 60
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 60
Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial 60
Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial 59
NT-proBNP and high-intensity care for acute heart failure: the STRONG-HF trial 59
Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis 59
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 58
Pre-admission beta-blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock-2 Registry 57
Assessing aortic flow with doppler echocardiography in cardiogenic shock: A crucial diagnostic tool 57
Safety and Efficacy Intravenous Istaroxime up to 60 hours for Patients with Pre-Cardiogenic Shock 56
Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF Trial 56
Mapping of current practices of palliative care for patients with heart failure throughout Europe: A scoping review 55
Functional Mitral Regurgitation and Heart Failure With Preserved Ejection Fraction: Clinical Implications and Management 55
Corticosteroid burst therapy in patients with acute heart failure: Design of the CORTAHF pilot study 55
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial 54
Impact of SGLT2 inhibitors on endothelial function and echocardiographic parameters in dilated cardiomyopathy 54
Left Main Spontaneous Coronary Artery Dissection: Clinical Features, Management, and Outcomes 53
Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction 53
Lactate Values and Mortality in Patients With Cardiogenic Shock: Insights From the Altshock-2 Registry 52
Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF 52
Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE-TR registry 52
Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF study 51
Is it NICE to measure natriuretic peptides after a hospitalization for heart failure? 50
February 2021 at a glance: focus on amyloidosis, myocarditis and cardiomyopathy 49
Increasing Evidence Supports the Benefits of Rapid Uptitration of the Neurohormonal Blockade in HFmrEF/HFpEF Patients With AHF 49
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: a sub-analysis of the STRONG-HF randomized clinical trial 49
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure 49
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry 48
Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction 47
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial 47
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 46
Remote pulmonary artery pressure-guided management of patients with heart failure: A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 46
Noncardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: insights from the STRONG-HF trial 46
Totale 7.049
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.885
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.885
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202236 0 0 0 0 2 1 2 0 2 0 3 26
2022/2023206 23 21 4 6 15 56 2 16 26 1 13 23
2023/2024622 27 11 52 33 30 71 42 17 150 21 43 125
2024/20251.864 13 22 81 152 144 140 203 94 161 225 370 259
2025/20264.783 440 595 355 677 411 282 527 228 346 361 334 227
Totale 7.511